Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3.
Eichkorn T, Lischalk JW, Hörner-Rieber J, Deng M, Meixner E, Krämer A, Hoegen P, Sandrini E, Regnery S, Held T, Harrabi S, Jungk C, Herfarth K, Debus J, König L. Eichkorn T, et al. Among authors: lischalk jw. J Neurooncol. 2023 May;162(3):489-501. doi: 10.1007/s11060-022-04217-y. Epub 2023 Jan 4. J Neurooncol. 2023. PMID: 36598613 Free PMC article.
Secondary Malignancy Risk Following Proton vs. X-ray Treatment of Mediastinal Malignant Lymphoma: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk.
König L, Haering P, Lang C, Splinter M, von Nettelbladt B, Weykamp F, Hoegen P, Lischalk JW, Herfarth K, Debus J, Hörner-Rieber J. König L, et al. Among authors: lischalk jw. Front Oncol. 2020 Jul 7;10:989. doi: 10.3389/fonc.2020.00989. eCollection 2020. Front Oncol. 2020. PMID: 32733794 Free PMC article.
Intensity Modulated Radiation Therapy (IMRT) With Simultaneously Integrated Boost Shortens Treatment Time and Is Noninferior to Conventional Radiation Therapy Followed by Sequential Boost in Adjuvant Breast Cancer Treatment: Results of a Large Randomized Phase III Trial (IMRT-MC2 Trial).
Hörner-Rieber J, Forster T, Hommertgen A, Haefner MF, Arians N, König L, Harrabi SB, Schlampp I, Weykamp F, Lischalk JW, Heinrich V, Weidner N, Hüsing J, Sohn C, Heil J, Hof H, Krug D, Debus J. Hörner-Rieber J, et al. Among authors: lischalk jw. Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1311-1324. doi: 10.1016/j.ijrobp.2020.12.005. Epub 2020 Dec 13. Int J Radiat Oncol Biol Phys. 2021. PMID: 33321192 Clinical Trial.
Stereotactic radiosurgery for brain metastases from pelvic gynecological malignancies: oncologic outcomes, validation of prognostic scores, and dosimetric evaluation.
Meixner E, Eichkorn T, Erdem S, König L, Lang K, Lischalk JW, Michel LL, Schneeweiss A, Smetanay K, Debus J, Hörner-Rieber J. Meixner E, et al. Among authors: lischalk jw. Int J Gynecol Cancer. 2022 Feb;32(2):172-180. doi: 10.1136/ijgc-2021-002906. Epub 2021 Nov 30. Int J Gynecol Cancer. 2022. PMID: 34848530
Radiation-induced contrast enhancement following proton radiotherapy for low-grade glioma depends on tumor characteristics and is rarer in children than adults.
Eichkorn T, Bauer J, Bahn E, Lischalk JW, Meixner E, Sandrini E, Regnery S, Held T, Hörner-Rieber J, Alber M, Herfarth K, Debus J, König L, Harrabi S. Eichkorn T, et al. Among authors: lischalk jw. Radiother Oncol. 2022 Jul;172:54-64. doi: 10.1016/j.radonc.2022.05.005. Epub 2022 May 11. Radiother Oncol. 2022. PMID: 35568281
Secondary Malignancy Risk Following Proton vs. X-ray Radiotherapy of Thymic Epithelial Tumors: A Comparative Modeling Study of Thoracic Organ-Specific Cancer Risk.
König L, Hörner-Rieber J, Forsthoefel M, Haering P, Meixner E, Eichkorn T, Krämer A, Mielke T, Tonndorf-Martini E, Haefner MF, Debus J, Lischalk JW. König L, et al. Among authors: lischalk jw. Cancers (Basel). 2022 May 13;14(10):2409. doi: 10.3390/cancers14102409. Cancers (Basel). 2022. PMID: 35626013 Free PMC article.
68 results